Once-weekly insulin efsitora alfa and daily degludec achieve comparable glycaemic control in 3 patient populations during phase 2: clinical insights from CGM assessments
DIABETOLOGIA(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
DIABETOLOGIA(2023)